Delivery Order SPE2DB20D1109-SPE2DB25FP44A
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.57 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $8,112 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 100 mg on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,450.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with a completion date of June 16, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government....
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order valued at $14,565.84 for Nucynta ER (extended-release tapentadol) 100mg tablets by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract was awarded without set-aside designation through competitive procurement to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP44ADelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,864.76 by the Defense Logistics Agency for Nucynta (tapentadol) 75 mg tablets in a quantity of 100 units. This firm fixed-price, non-set-aside contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Nucynta tablets represent pain management pharmaceuticals within the company's extensive offerings of brand-name and generic drugs, specialty medications, and medical supplies. This delivery order demonstrates the company's continued role in fulfilling federal pharmaceutical requirements through its established framework contract with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/23/25 |